Lyell Immunopharma, Inc. (LYEL)

USD 0.44

(1.39%)

Revenue Summary of Lyell Immunopharma, Inc.

  • Lyell Immunopharma, Inc.'s latest annual revenue in 2023 was 130 Thousand USD , down -99.85% from previous year.
  • Lyell Immunopharma, Inc.'s latest quarterly revenue in 2024 Q2 was 13 Thousand USD , up 333.33% from previous quarter.
  • Lyell Immunopharma, Inc. reported a annual revenue of 84.68 Million USD in annual revenue 2022, up 695.15% from previous year.
  • Lyell Immunopharma, Inc. reported a annual revenue of 10.65 Million USD in annual revenue 2021, up 37.31% from previous year.
  • Lyell Immunopharma, Inc. reported a quarterly revenue of 3000.00 USD for 2024 Q1, down -76.92% from previous quarter.
  • Lyell Immunopharma, Inc. reported a quarterly revenue of 25 Thousand USD for 2023 Q3, down -7.41% from previous quarter.

Annual Revenue Chart of Lyell Immunopharma, Inc. (2023 - 2019)

Historical Annual Revenue of Lyell Immunopharma, Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 130 Thousand USD -99.85%
2022 84.68 Million USD 695.15%
2021 10.65 Million USD 37.31%
2020 7.75 Million USD 1080.52%
2019 657 Thousand USD 0.0%

Peer Revenue Comparison of Lyell Immunopharma, Inc.

Name Revenue Revenue Difference
Agenus Inc. 156.31 Million USD 99.917%
Immix Biopharma, Inc. - USD -Infinity%
Keros Therapeutics, Inc. 151 Thousand USD 13.907%
Caribou Biosciences, Inc. 34.47 Million USD 99.623%
Madrigal Pharmaceuticals, Inc. - USD -Infinity%
MiMedx Group, Inc. 321.47 Million USD 99.96%
Novavax, Inc. 983.7 Million USD 99.987%
Seer, Inc. 15.18 Million USD 99.144%
Acelyrin, Inc. - USD -Infinity%
Xeris Biopharma Holdings, Inc. 163.91 Million USD 99.921%
IO Biotech, Inc. - USD -Infinity%
Ardelyx, Inc. 124.45 Million USD 99.896%
C4 Therapeutics, Inc. 20.75 Million USD 99.374%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Fortress Biotech, Inc. 84.51 Million USD 99.846%
Fortress Biotech, Inc. 84.51 Million USD 99.846%
Geron Corporation 237 Thousand USD 45.148%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.946%
HOOKIPA Pharma Inc. 20.12 Million USD 99.354%
Incyte Corporation 3.69 Billion USD 99.996%
Innoviva, Inc. 310.46 Million USD 99.958%
Kintara Therapeutics, Inc. - USD -Infinity%
ChromaDex Corporation 83.57 Million USD 99.844%
Ligand Pharmaceuticals Incorporated 131.31 Million USD 99.901%
MEI Pharma, Inc. 65.29 Million USD 99.801%
NextCure, Inc. - USD -Infinity%
Onconetix, Inc. 58.46 Thousand USD -122.355%
Oncternal Therapeutics, Inc. 785 Thousand USD 83.439%
GlycoMimetics, Inc. 10 Thousand USD -1200.0%
IDEAYA Biosciences, Inc. 23.38 Million USD 99.444%
Vaxcyte, Inc. - USD -Infinity%
Precigen, Inc. 6.22 Million USD 97.912%
Pharming Group N.V. 245.31 Million USD 99.947%
ContextLogic Inc. 287 Million USD 99.955%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 98.921%
Pyxis Oncology, Inc. - USD -Infinity%
Rigel Pharmaceuticals, Inc. 116.88 Million USD 99.889%
AlloVir, Inc. - USD -Infinity%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Marinus Pharmaceuticals, Inc. 30.98 Million USD 99.58%
Salarius Pharmaceuticals, Inc. - USD -Infinity%
Summit Therapeutics Inc. - USD -Infinity%
Syndax Pharmaceuticals, Inc. - USD -Infinity%
Sensei Biotherapeutics, Inc. - USD -Infinity%
Senti Biosciences, Inc. 2.56 Million USD 94.924%
BioXcel Therapeutics, Inc. 1.38 Million USD 90.58%
Alaunos Therapeutics, Inc. 5000.00 USD -2500.0%
Entrada Therapeutics, Inc. 129.01 Million USD 99.899%
Psyence Biomedical Ltd. - USD -Infinity%
Outlook Therapeutics, Inc. - USD -Infinity%
Chimerix, Inc. 324 Thousand USD 59.877%
PDS Biotechnology Corporation - USD -Infinity%
Windtree Therapeutics, Inc. - USD -Infinity%
CRISPR Therapeutics AG 371.2 Million USD 99.965%
Wave Life Sciences Ltd. 113.3 Million USD 99.885%
Phathom Pharmaceuticals, Inc. 682 Thousand USD 80.938%
Pieris Pharmaceuticals, Inc. 42.81 Million USD 99.696%
CARGO Therapeutics, Inc. Common Stock - USD -Infinity%
Precision BioSciences, Inc. 48.72 Million USD 99.733%
Dyadic International, Inc. 2.89 Million USD 95.515%
Elevation Oncology, Inc. - USD -Infinity%
Eton Pharmaceuticals, Inc. 31.64 Million USD 99.589%
Akebia Therapeutics, Inc. 194.62 Million USD 99.933%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 99.993%
Aptorum Group Limited 431.37 Thousand USD 69.864%
Bicycle Therapeutics plc 26.97 Million USD 99.518%
Telomir Pharmaceuticals, Inc. Common Stock - USD -Infinity%
Clearside Biomedical, Inc. 8.22 Million USD 98.42%
Inhibikase Therapeutics, Inc. 260.5 Thousand USD 50.096%
GT Biopharma, Inc. - USD -Infinity%
Alkermes plc 1.66 Billion USD 99.992%
Verrica Pharmaceuticals Inc. 5.12 Million USD 97.463%
Jaguar Health, Inc. 9.76 Million USD 98.668%
VistaGen Therapeutics, Inc. 1.06 Million USD 87.782%
AbCellera Biologics Inc. 38.02 Million USD 99.658%
PureTech Health plc 3.33 Million USD 96.096%
TransCode Therapeutics, Inc. - USD -Infinity%
Sangamo Therapeutics, Inc. 176.23 Million USD 99.926%
SELLAS Life Sciences Group, Inc. - USD -Infinity%
Barinthus Biotherapeutics plc 802 Thousand USD 83.791%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Aadi Bioscience, Inc. 24.35 Million USD 99.466%
AnaptysBio, Inc. 17.15 Million USD 99.242%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
ESSA Pharma Inc. - USD -Infinity%
Molecular Templates, Inc. 57.3 Million USD 99.773%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 62.83 Million USD 99.793%
Vaxxinity, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
Sol-Gel Technologies Ltd. 1.55 Million USD 91.634%
Janux Therapeutics, Inc. 8.08 Million USD 98.392%
Structure Therapeutics Inc. - USD -Infinity%
Longboard Pharmaceuticals, Inc. - USD -Infinity%
Stoke Therapeutics, Inc. 8.78 Million USD 98.519%
ImmuCell Corporation 17.47 Million USD 99.256%
Lantern Pharma Inc. - USD -Infinity%
VYNE Therapeutics Inc. 424 Thousand USD 69.34%
Ocuphire Pharma, Inc. 19.04 Million USD 99.318%
Opthea Limited 261.85 Thousand USD 50.355%
Avidity Biosciences, Inc. 9.56 Million USD 98.64%
Syros Pharmaceuticals, Inc. 9.93 Million USD 98.692%
Fate Therapeutics, Inc. 63.53 Million USD 99.795%
Inhibrx Biosciences, Inc. 1.8 Million USD 92.778%
Catalyst Pharmaceuticals, Inc. 398.2 Million USD 99.967%
Orchestra BioMed Holdings, Inc. 2.76 Million USD 95.29%
Alzamend Neuro, Inc. - USD -Infinity%
Rocket Pharmaceuticals, Inc. - USD -Infinity%
Aptose Biosciences Inc. - USD -Infinity%
ZyVersa Therapeutics, Inc. - USD -Infinity%
Soligenix, Inc. 839.35 Thousand USD 84.512%
Century Therapeutics, Inc. 2.23 Million USD 94.183%
Kura Oncology, Inc. - USD -Infinity%
TScan Therapeutics, Inc. 21.04 Million USD 99.382%
Intensity Therapeutics, Inc. - USD -Infinity%
Ocean Biomedical, Inc. - USD -Infinity%
CytomX Therapeutics, Inc. 101.21 Million USD 99.872%
Autolus Therapeutics plc 1.69 Million USD 92.344%
Mineralys Therapeutics, Inc. - USD -Infinity%
EyePoint Pharmaceuticals, Inc. 46.01 Million USD 99.718%
Eterna Therapeutics Inc. 68 Thousand USD -91.176%
Adaptive Biotechnologies Corporation 170.27 Million USD 99.924%
GRI Bio, Inc. 21.76 Million USD 99.403%
Xenetic Biosciences, Inc. 2.53 Million USD 94.882%
Tenaya Therapeutics, Inc. - USD -Infinity%
IGM Biosciences, Inc. 2.13 Million USD 93.897%
INmune Bio, Inc. 155 Thousand USD 16.129%
Heron Therapeutics, Inc. 127.04 Million USD 99.898%
SAB Biotherapeutics, Inc. 2.23 Million USD 94.194%
Pasithea Therapeutics Corp. - USD -Infinity%
Entero Therapeutics, Inc. - USD -Infinity%
Milestone Pharmaceuticals Inc. 1 Million USD 87.0%
X4 Pharmaceuticals, Inc. - USD -Infinity%
Atara Biotherapeutics, Inc. 8.57 Million USD 98.484%
Coherus BioSciences, Inc. 257.24 Million USD 99.949%
Verastem, Inc. - USD -Infinity%
Abeona Therapeutics Inc. 3.5 Million USD 96.286%
Pliant Therapeutics, Inc. 1.58 Million USD 91.772%
Tonix Pharmaceuticals Holding Corp. 7.76 Million USD 98.326%
Histogen Inc. 3.76 Million USD 96.551%
Aprea Therapeutics, Inc. 583.23 Thousand USD 77.71%
Surrozen, Inc. - USD -Infinity%
Organovo Holdings, Inc. 109 Thousand USD -19.266%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Ovid Therapeutics Inc. 391.69 Thousand USD 66.811%
Panbela Therapeutics, Inc. - USD -Infinity%
CASI Pharmaceuticals, Inc. 33.87 Million USD 99.616%
Cadrenal Therapeutics, Inc. Common Stock - USD -Infinity%
Centessa Pharmaceuticals plc 6.85 Million USD 98.103%
Hepion Pharmaceuticals, Inc. - USD -Infinity%
Arcturus Therapeutics Holdings Inc. 157.74 Million USD 99.918%
BioRestorative Therapies, Inc. 145.8 Thousand USD 10.837%
Apollomics, Inc. 821 Thousand USD 84.166%
Amarin Corporation plc 306.91 Million USD 99.958%
Mesoblast Limited 5.9 Million USD 97.797%
Turnstone Biologics Corp. 19.3 Million USD 99.327%
Kymera Therapeutics, Inc. 78.59 Million USD 99.835%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd - USD -Infinity%
Aurinia Pharmaceuticals Inc. 175.51 Million USD 99.926%
BriaCell Therapeutics Corp. - USD -Infinity%
Monopar Therapeutics Inc. - USD -Infinity%
Exelixis, Inc. 1.83 Billion USD 99.993%
Better Therapeutics, Inc. - USD -Infinity%
Nurix Therapeutics, Inc. 76.98 Million USD 99.831%
Apellis Pharmaceuticals, Inc. 396.59 Million USD 99.967%
NLS Pharmaceutics AG - USD -Infinity%
Dermata Therapeutics, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Gritstone bio, Inc. 1.33 Million USD 90.233%
Jasper Therapeutics, Inc. - USD -Infinity%
TNF Pharmaceuticals, Inc. - USD -Infinity%
Avid Bioservices, Inc. 139.91 Million USD 99.907%
Insmed Incorporated 305.2 Million USD 99.957%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
MediWound Ltd. 18.68 Million USD 99.304%
OmniAb, Inc. 34.16 Million USD 99.619%
Alector, Inc. 97.06 Million USD 99.866%
Seres Therapeutics, Inc. 126.32 Million USD 99.897%
Checkpoint Therapeutics, Inc. 103 Thousand USD -26.214%
Zai Lab Limited 266.71 Million USD 99.951%
Revance Therapeutics, Inc. 234.04 Million USD 99.944%
Aura Biosciences, Inc. - USD -Infinity%
Immunic, Inc. - USD -Infinity%
Tarsus Pharmaceuticals, Inc. 17.44 Million USD 99.255%
Veracyte, Inc. 361.05 Million USD 99.964%
InMed Pharmaceuticals Inc. 4.59 Million USD 97.173%
FibroGen, Inc. 147.75 Million USD 99.912%
SeaStar Medical Holding Corporation - USD -Infinity%
Adial Pharmaceuticals, Inc. - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 147.8 Thousand USD 12.046%
Jazz Pharmaceuticals plc 3.83 Billion USD 99.997%
Cyclacel Pharmaceuticals, Inc. 420 Thousand USD 69.048%
Amylyx Pharmaceuticals, Inc. 380.78 Million USD 99.966%
TG Therapeutics, Inc. 233.66 Million USD 99.944%
Galecto, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Fortrea Holdings Inc. 3.1 Billion USD 99.996%
KalVista Pharmaceuticals, Inc. - USD -Infinity%
Aptevo Therapeutics Inc. - USD -Infinity%
XBiotech Inc. - USD -Infinity%
Jasper Therapeutics, Inc. - USD -Infinity%
Lyra Therapeutics, Inc. 1.55 Million USD 91.656%
Foghorn Therapeutics Inc. 34.15 Million USD 99.619%
Y-mAbs Therapeutics, Inc. 84.81 Million USD 99.847%
Theravance Biopharma, Inc. 57.42 Million USD 99.774%
Ultragenyx Pharmaceutical Inc. 434.24 Million USD 99.97%
Metagenomi, Inc. Common Stock 44.75 Million USD 99.71%
BioCryst Pharmaceuticals, Inc. 331.41 Million USD 99.961%
Gain Therapeutics, Inc. 55.18 Thousand USD -135.593%
Cartesian Therapeutics, Inc. 26 Million USD 99.5%
NexImmune, Inc. - USD -Infinity%
Creative Medical Technology Holdings, Inc. 9000.00 USD -1344.444%
Marker Therapeutics, Inc. 3.31 Million USD 96.074%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 99.999%
Chemomab Therapeutics Ltd. - USD -Infinity%
RAPT Therapeutics, Inc. - USD -Infinity%
Ainos, Inc. 122.11 Thousand USD -6.46%
Pluri Inc. 326 Thousand USD 60.123%
Prothena Corporation plc 91.37 Million USD 99.858%
Adaptimmune Therapeutics plc 60.28 Million USD 99.784%
Celularity Inc. 22.77 Million USD 99.429%
Rallybio Corporation - USD -Infinity%
Cue Biopharma, Inc. 5.49 Million USD 97.632%
MeiraGTx Holdings plc 14.01 Million USD 99.073%
Omeros Corporation - USD -Infinity%
Humacyte, Inc. - USD -Infinity%
Immunocore Holdings plc 249.42 Million USD 99.948%
Cocrystal Pharma, Inc. - USD -Infinity%
Cidara Therapeutics, Inc. 63.9 Million USD 99.797%
Blueprint Medicines Corporation 249.38 Million USD 99.948%
CalciMedica, Inc. - USD -Infinity%
Cabaletta Bio, Inc. - USD -Infinity%
Scholar Rock Holding Corporation - USD -Infinity%
Sana Biotechnology, Inc. - USD -Infinity%
Pulmatrix, Inc. 7.29 Million USD 98.219%
Elicio Therapeutics, Inc. - USD -Infinity%
Vigil Neuroscience, Inc. - USD -Infinity%
Intellia Therapeutics, Inc. 36.27 Million USD 99.642%
Adlai Nortye Ltd. American Depositary Shares 4.99 Million USD 97.398%
Cytokinetics, Incorporated 7.53 Million USD 98.274%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Nutriband Inc. 2.08 Million USD 93.766%
Protara Therapeutics, Inc. - USD -Infinity%
Vor Biopharma Inc. - USD -Infinity%
Roivant Sciences Ltd. 124.79 Million USD 99.896%
Evogene Ltd. 5.64 Million USD 97.695%
ProKidney Corp. - USD -Infinity%
Applied Therapeutics, Inc. 9.99 Million USD 98.699%
Hoth Therapeutics, Inc. - USD -Infinity%
BridgeBio Pharma, Inc. 9.3 Million USD 98.603%
CorMedix Inc. - USD -Infinity%
BioLineRx Ltd. 4.8 Million USD 97.292%
Tango Therapeutics, Inc. 36.52 Million USD 99.644%
Galectin Therapeutics Inc. - USD -Infinity%
Atai Life Sciences N.V. 314 Thousand USD 58.599%
Renovaro Biosciences Inc. - USD -Infinity%
Aerovate Therapeutics, Inc. - USD -Infinity%
Zentalis Pharmaceuticals, Inc. - USD -Infinity%
Sagimet Biosciences Inc. 2 Million USD 93.5%
MediciNova, Inc. 1 Million USD 87.0%
Praxis Precision Medicines, Inc. 2.44 Million USD 94.687%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -661.793%
GeoVax Labs, Inc. - USD -Infinity%
Axsome Therapeutics, Inc. 270.6 Million USD 99.952%
Biomea Fusion, Inc. - USD -Infinity%
PTC Therapeutics, Inc. 937.82 Million USD 99.986%
Mereo BioPharma Group plc 10 Million USD 98.7%
Cullinan Oncology, Inc. - USD -Infinity%
Absci Corporation 5.71 Million USD 97.726%
NRx Pharmaceuticals, Inc. - USD -Infinity%
4D Molecular Therapeutics, Inc. 20.72 Million USD 99.373%
Dyne Therapeutics, Inc. - USD -Infinity%
Kiniksa Pharmaceuticals, Ltd. 270.25 Million USD 99.952%
Ventyx Biosciences, Inc. - USD -Infinity%
Allakos Inc. - USD -Infinity%
Imunon, Inc. - USD -Infinity%
Fulcrum Therapeutics, Inc. 2.8 Million USD 95.365%
Corcept Therapeutics Incorporated 482.37 Million USD 99.973%
BioAtla, Inc. - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
Bio-Path Holdings, Inc. - USD -Infinity%
Allogene Therapeutics, Inc. 95 Thousand USD -36.842%
Larimar Therapeutics, Inc. - USD -Infinity%
XOMA Corporation 4.75 Million USD 97.268%
Kezar Life Sciences, Inc. 7 Million USD 98.143%
Cara Therapeutics, Inc. 20.96 Million USD 99.38%
aTyr Pharma, Inc. 353 Thousand USD 63.173%
Aligos Therapeutics, Inc. 15.52 Million USD 99.163%
Akero Therapeutics, Inc. - USD -Infinity%
Viridian Therapeutics, Inc. 314 Thousand USD 58.599%
Eliem Therapeutics, Inc. - USD -Infinity%
EyeGate Pharmaceuticals, Inc. 12.05 Thousand USD -978.033%
Akari Therapeutics, Plc - USD -Infinity%
Tevogen Bio Holdings Inc. - USD -Infinity%
Halozyme Therapeutics, Inc. 829.25 Million USD 99.984%
Lexaria Bioscience Corp. 226.2 Thousand USD 42.531%
UroGen Pharma Ltd. 82.71 Million USD 99.843%
Sutro Biopharma, Inc. 153.73 Million USD 99.915%
ZIVO Bioscience, Inc. 27.65 Thousand USD -370.163%
Orgenesis Inc. 530 Thousand USD 75.472%
Entera Bio Ltd. - USD -Infinity%
GH Research PLC - USD -Infinity%
Lisata Therapeutics, Inc. - USD -Infinity%
Reneo Pharmaceuticals, Inc. - USD -Infinity%
Xencor, Inc. 168.33 Million USD 99.923%
60 Degrees Pharmaceuticals, Inc. 253.57 Thousand USD 48.733%
Replimune Group, Inc. - USD -Infinity%
Coeptis Therapeutics Holdings, Inc. - USD -Infinity%
Vanda Pharmaceuticals Inc. 192.64 Million USD 99.933%
Lexaria Bioscience Corp. 226.2 Thousand USD 42.531%
Portage Biotech Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -661.793%
Olema Pharmaceuticals, Inc. - USD -Infinity%
OncoCyte Corporation 1.5 Million USD 91.351%
Qualigen Therapeutics, Inc. 5.2 Million USD 97.502%
Processa Pharmaceuticals, Inc. - USD -Infinity%
Purple Biotech Ltd. - USD -Infinity%
CollPlant Biotechnologies Ltd. 10.95 Million USD 98.814%
scPharmaceuticals Inc. 13.59 Million USD 99.044%
ProMIS Neurosciences, Inc. - USD -Infinity%
HilleVax, Inc. - USD -Infinity%
NeuroSense Therapeutics Ltd. - USD -Infinity%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
Neumora Therapeutics, Inc. Common Stock - USD -Infinity%
Atossa Therapeutics, Inc. - USD -Infinity%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Savara Inc. - USD -Infinity%
Curis, Inc. 10.02 Million USD 98.703%
Daré Bioscience, Inc. 2.8 Million USD 95.37%
Carmell Therapeutics Corporation - USD -Infinity%
Titan Pharmaceuticals, Inc. 184 Thousand USD 29.348%
Achieve Life Sciences, Inc. - USD -Infinity%
BeiGene, Ltd. 2.45 Billion USD 99.995%
Kiromic BioPharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. Warrant 11.58 Million USD 98.877%
Protagonist Therapeutics, Inc. 60 Million USD 99.783%
Erasca, Inc. - USD -Infinity%
bluebird bio, Inc. 29.49 Million USD 99.559%
Protagenic Therapeutics, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 99.995%
DBV Technologies S.A. 15.72 Million USD 99.173%
Protagenic Therapeutics, Inc. - USD -Infinity%
Moderna, Inc. 6.84 Billion USD 99.998%
Vincerx Pharma, Inc. - USD -Infinity%
Fresh Tracks Therapeutics, Inc. 8 Million USD 98.376%
Acrivon Therapeutics, Inc. Common Stock - USD -Infinity%
Travere Therapeutics, Inc. 145.23 Million USD 99.91%
Monte Rosa Therapeutics, Inc. - USD -Infinity%
Spruce Biosciences, Inc. 10.08 Million USD 98.711%
Celldex Therapeutics, Inc. 6.88 Million USD 98.111%
Cogent Biosciences, Inc. - USD -Infinity%
MacroGenics, Inc. 58.74 Million USD 99.779%
RenovoRx, Inc. - USD -Infinity%
Adicet Bio, Inc. - USD -Infinity%
Prime Medicine, Inc. - USD -Infinity%
Aditxt, Inc. 645.17 Thousand USD 79.85%
Adagene Inc. 18.11 Million USD 99.282%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 87.985%
Maravai LifeSciences Holdings, Inc. 288.94 Million USD 99.955%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Voyager Therapeutics, Inc. 250 Million USD 99.948%
SciSparc Ltd. 2.87 Million USD 95.485%
Vericel Corporation 197.51 Million USD 99.934%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. - USD -Infinity%
Generation Bio Co. 5.9 Million USD 97.798%
Astria Therapeutics, Inc. - USD -Infinity%
Black Diamond Therapeutics, Inc. - USD -Infinity%
Arcutis Biotherapeutics, Inc. 59.6 Million USD 99.782%
Invivyd, Inc. - USD -Infinity%
Relay Therapeutics, Inc. 25.54 Million USD 99.491%
Quoin Pharmaceuticals, Ltd. - USD -Infinity%
Spero Therapeutics, Inc. 96.73 Million USD 99.866%
Artelo Biosciences, Inc. - USD -Infinity%
2seventy bio, Inc. 100.38 Million USD 99.871%
ADMA Biologics, Inc. 258.21 Million USD 99.95%
Clene Inc. 654 Thousand USD 80.122%
Capricor Therapeutics, Inc. 25.17 Million USD 99.484%
Boundless Bio, Inc. Common Stock - USD -Infinity%
GeoVax Labs, Inc. - USD -Infinity%
Recursion Pharmaceuticals, Inc. 44.57 Million USD 99.708%
Citius Pharmaceuticals, Inc. - USD -Infinity%
Contineum Therapeutics, Inc. Class A Common Stock 50 Million USD 99.74%
Relmada Therapeutics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. 107 Thousand USD -21.495%
ALX Oncology Holdings Inc. - USD -Infinity%
Vir Biotechnology, Inc. 86.18 Million USD 99.849%
Evaxion Biotech A/S 73.11 Thousand USD -77.809%
Ocular Therapeutix, Inc. 58.44 Million USD 99.778%
Verve Therapeutics, Inc. 11.75 Million USD 98.894%
Trevena, Inc. 3.12 Million USD 95.84%
Surrozen, Inc. - USD -Infinity%
Tyra Biosciences, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Galmed Pharmaceuticals Ltd. - USD -Infinity%
Unity Biotechnology, Inc. - USD -Infinity%
Tenax Therapeutics, Inc. - USD -Infinity%
Terns Pharmaceuticals, Inc. - USD -Infinity%
ACADIA Pharmaceuticals Inc. 726.43 Million USD 99.982%
Connect Biopharma Holdings Limited - USD -Infinity%
Clearmind Medicine Inc. - USD -Infinity%
Kronos Bio, Inc. 6.28 Million USD 97.933%
Bolt Biotherapeutics, Inc. 7.87 Million USD 98.349%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Viking Therapeutics, Inc. - USD -Infinity%
Statera Biopharma, Inc. - USD -Infinity%
ImmunityBio, Inc. 622 Thousand USD 79.1%
Korro Bio, Inc. - USD -Infinity%
Kineta, Inc. 5.44 Million USD 97.611%
BioVie Inc. - USD -Infinity%
Codexis, Inc. 70.14 Million USD 99.815%
Celularity Inc. 22.77 Million USD 99.429%
Crinetics Pharmaceuticals, Inc. 4.01 Million USD 96.761%
Celcuity Inc. - USD -Infinity%
Virax Biolabs Group Limited 156.41 Thousand USD 16.89%
Cibus, Inc. 1.81 Million USD 92.845%
Eledon Pharmaceuticals, Inc. - USD -Infinity%
IN8bio, Inc. - USD -Infinity%
Kodiak Sciences Inc. - USD -Infinity%
Annexon, Inc. - USD -Infinity%
Adverum Biotechnologies, Inc. 3.6 Million USD 96.389%
Assembly Biosciences, Inc. 7.16 Million USD 98.185%
Avalo Therapeutics, Inc. 1.92 Million USD 93.243%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 99.983%
Eyenovia, Inc. 3787.00 USD -3332.796%
Puma Biotechnology, Inc. 235.63 Million USD 99.945%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Xilio Therapeutics, Inc. - USD -Infinity%
Arcellx, Inc. 110.31 Million USD 99.882%
Cardiff Oncology, Inc. 488 Thousand USD 73.361%
Enanta Pharmaceuticals, Inc. 79.2 Million USD 99.836%
Regulus Therapeutics Inc. - USD -Infinity%
Moolec Science SA 905.04 Thousand USD 85.636%
Acumen Pharmaceuticals, Inc. - USD -Infinity%
LAVA Therapeutics N.V. 6.76 Million USD 98.079%
Royalty Pharma plc 2.35 Billion USD 99.994%
Atea Pharmaceuticals, Inc. - USD -Infinity%
Greenwich LifeSciences, Inc. - USD -Infinity%
TFF Pharmaceuticals, Inc. 733.87 Thousand USD 82.286%
Mersana Therapeutics, Inc. 36.85 Million USD 99.647%
Humacyte, Inc. - USD -Infinity%
89bio, Inc. - USD -Infinity%
PMV Pharmaceuticals, Inc. - USD -Infinity%
Avenue Therapeutics, Inc. - USD -Infinity%
Genelux Corporation 170 Thousand USD 23.529%
Trevi Therapeutics, Inc. - USD -Infinity%
Lexicon Pharmaceuticals, Inc. 1.2 Million USD 89.203%
Notable Labs, Ltd. 310 Thousand USD 58.065%
Liquidia Corporation 17.48 Million USD 99.257%
Mustang Bio, Inc. - USD -Infinity%
Immunovant, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 87.985%
Arbutus Biopharma Corporation 18.14 Million USD 99.283%
DiaMedica Therapeutics Inc. - USD -Infinity%
Vera Therapeutics, Inc. 1.86 Million USD 93.018%
Acasti Pharma Inc. - USD -Infinity%
MiNK Therapeutics, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. - USD -Infinity%
Xenon Pharmaceuticals Inc. - USD -Infinity%
Elevai Labs, Inc. Common Stock 1.71 Million USD 92.409%
NeuroBo Pharmaceuticals, Inc. - USD -Infinity%
Tempest Therapeutics, Inc. - USD -Infinity%
Soleno Therapeutics, Inc. - USD -Infinity%
PepGen Inc. - USD -Infinity%
Moleculin Biotech, Inc. - USD -Infinity%
United Therapeutics Corporation 2.32 Billion USD 99.994%
Nuvectis Pharma, Inc. - USD -Infinity%
Solid Biosciences Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Immuneering Corporation - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. 72.1 Thousand USD -80.3%
Belite Bio, Inc - USD -Infinity%
XOMA Corporation 4.75 Million USD 97.268%
ARS Pharmaceuticals, Inc. 30 Thousand USD -333.333%
Bionomics Limited - USD -Infinity%
Apogee Therapeutics, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
uniQure N.V. 15.84 Million USD 99.179%
Cassava Sciences, Inc. - USD -Infinity%
Estrella Immunopharma, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 64.7 Million USD 99.799%
Forte Biosciences, Inc. - USD -Infinity%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. - USD -Infinity%
Conduit Pharmaceuticals Inc. - USD -Infinity%
SeaStar Medical Holding Corporation - USD -Infinity%
FibroBiologics, Inc. Common Stock - USD -Infinity%
Altimmune, Inc. 426 Thousand USD 69.484%
Amicus Therapeutics, Inc. 399.35 Million USD 99.967%
Alpha Tau Medical Ltd. - USD -Infinity%
Compugen Ltd. 33.45 Million USD 99.611%
Peak Bio, Inc. 367.87 Thousand USD 64.662%
Zevra Therapeutics, Inc. 27.46 Million USD 99.527%
Benitec Biopharma Inc. 216 Thousand USD 39.815%
Spyre Therapeutics, Inc. 886 Thousand USD 85.327%
NKGen Biotech, Inc. Common Stock - USD -Infinity%
Zura Bio Limited - USD -Infinity%
PolyPid Ltd. - USD -Infinity%
Aileron Therapeutics, Inc. - USD -Infinity%
NKGen Biotech, Inc. Warrants - USD -Infinity%
Instil Bio, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.989%
Immunome, Inc. 14.01 Million USD 99.073%
Compass Therapeutics, Inc. - USD -Infinity%
Verona Pharma plc - USD -Infinity%
enGene Holdings Inc. Warrants - USD -Infinity%
Shattuck Labs, Inc. 1.65 Million USD 92.154%
CervoMed Inc. 7.14 Million USD 98.181%
LENZ Therapeutics, Inc. - USD -Infinity%
Plus Therapeutics, Inc. 4.91 Million USD 97.354%
Dianthus Therapeutics, Inc. 2.82 Million USD 95.4%
Moolec Science SA 905.04 Thousand USD 85.636%
Enveric Biosciences, Inc. - USD -Infinity%
Inovio Pharmaceuticals, Inc. 832.01 Thousand USD 84.375%
Design Therapeutics, Inc. - USD -Infinity%
Leap Therapeutics, Inc. - USD -Infinity%
NeurAxis, Inc. 2.46 Million USD 94.716%
Seelos Therapeutics, Inc. 2.2 Million USD 94.099%
Lumos Pharma, Inc. 2.05 Million USD 93.662%
Achilles Therapeutics plc - USD -Infinity%
enGene Holdings Inc. Common Stock - USD -Infinity%
180 Life Sciences Corp. - USD -Infinity%
Opiant Pharmaceuticals, Inc. 40.72 Million USD 99.681%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Nutriband Inc. 2.08 Million USD 93.766%
ORIC Pharmaceuticals, Inc. - USD -Infinity%
CG Oncology, Inc. Common stock 204 Thousand USD 36.275%
Fractyl Health, Inc. Common Stock 120 Thousand USD -8.333%
Rani Therapeutics Holdings, Inc. - USD -Infinity%
MoonLake Immunotherapeutics - USD -Infinity%
Palisade Bio, Inc. 250 Thousand USD 48.0%
Tourmaline Bio, Inc. - USD -Infinity%
Beam Therapeutics Inc. 377.7 Million USD 99.966%
Neurogene Inc. - USD -Infinity%
Mirum Pharmaceuticals, Inc. 186.37 Million USD 99.93%
AEON Biopharma, Inc. - USD -Infinity%
Sesen Bio, Inc. 40 Million USD 99.675%
Enliven Therapeutics, Inc. - USD -Infinity%
Kiora Pharmaceuticals, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 1.18 Million USD 89.066%
Taysha Gene Therapies, Inc. 15.45 Million USD 99.159%
Athira Pharma, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD 77.193%
HCW Biologics Inc. 2.84 Million USD 95.425%
XOMA Corporation 4.75 Million USD 97.268%
Nektar Therapeutics 90.12 Million USD 99.856%
Arvinas, Inc. 78.5 Million USD 99.834%
Tevogen Bio Holdings Inc. - USD -Infinity%
Merus N.V. 43.94 Million USD 99.704%
Omega Therapeutics, Inc. 3.09 Million USD 95.798%
Quince Therapeutics, Inc. - USD -Infinity%
Rezolute, Inc. - USD -Infinity%
Clene Inc. 654 Thousand USD 80.122%
Indaptus Therapeutics, Inc. - USD -Infinity%
BeyondSpring Inc. 1.75 Million USD 92.576%
Synlogic, Inc. 3.37 Million USD 96.144%
Allarity Therapeutics, Inc. - USD -Infinity%
Phio Pharmaceuticals Corp. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD 64.662%
Werewolf Therapeutics, Inc. 19.94 Million USD 99.348%
Krystal Biotech, Inc. 50.69 Million USD 99.744%
Karyopharm Therapeutics Inc. 146.03 Million USD 99.911%
SpringWorks Therapeutics, Inc. 5.44 Million USD 97.613%
Lipella Pharmaceuticals Inc. 449.61 Thousand USD 71.087%
MannKind Corporation 198.96 Million USD 99.935%
Ikena Oncology, Inc. 9.16 Million USD 98.581%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 113.45 Million USD 99.885%
Gossamer Bio, Inc. - USD -Infinity%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Legend Biotech Corporation 285.14 Million USD 99.954%
Mural Oncology plc - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -3150.0%
PaxMedica, Inc. Common Stock - USD -Infinity%
Disc Medicine, Inc. - USD -Infinity%
Champions Oncology, Inc. 50.15 Million USD 99.741%
REGENXBIO Inc. 90.24 Million USD 99.856%
Ensysce Biosciences, Inc. 2.23 Million USD 94.172%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. - USD -Infinity%
Edgewise Therapeutics, Inc. - USD -Infinity%
Vaxart, Inc. 7.37 Million USD 98.238%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. - USD -Infinity%
Cellectis S.A. 755 Thousand USD 82.781%
Longeveron Inc. 709 Thousand USD 81.664%
Repare Therapeutics Inc. 51.13 Million USD 99.746%
Sarepta Therapeutics, Inc. 1.24 Billion USD 99.99%
Inozyme Pharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. 11.58 Million USD 98.877%
Nymox Pharmaceutical Corporation - USD -Infinity%
Third Harmonic Bio, Inc. - USD -Infinity%
ArriVent BioPharma, Inc. Common Stock - USD -Infinity%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 210 Thousand USD 38.095%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 99.999%
Denali Therapeutics Inc. 330.53 Million USD 99.961%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 16.29 Million USD 99.202%
Corvus Pharmaceuticals, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Passage Bio, Inc. - USD -Infinity%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. - USD -Infinity%
Day One Biopharmaceuticals, Inc. - USD -Infinity%
Oramed Pharmaceuticals Inc. 2.7 Million USD 95.191%
Scinai Immunotherapeutics Ltd. - USD -Infinity%
Rhythm Pharmaceuticals, Inc. 77.42 Million USD 99.832%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 152.43 Thousand USD 14.715%
Carisma Therapeutics, Inc. 14.91 Million USD 99.129%
Unicycive Therapeutics, Inc. 675 Thousand USD 80.741%
OmniAb, Inc. 34.16 Million USD 99.619%
Anew Medical, Inc. - USD -Infinity%
Fennec Pharmaceuticals Inc. 21.25 Million USD 99.388%
Lipocine Inc. -2.85 Million USD 104.56%
Lexeo Therapeutics, Inc. Common Stock - USD -Infinity%
Nautilus Biotechnology, Inc. - USD -Infinity%
SAB Biotherapeutics, Inc. 2.23 Million USD 94.194%
G1 Therapeutics, Inc. 82.51 Million USD 99.842%
Bellerophon Therapeutics, Inc. - USD -Infinity%
Sage Therapeutics, Inc. 86.45 Million USD 99.85%
Ocugen, Inc. 6.03 Million USD 97.846%
Mind Medicine (MindMed) Inc. - USD -Infinity%
Q32 Bio Inc. 1.15 Million USD 88.754%
Brainstorm Cell Therapeutics Inc. - USD -Infinity%
Alumis Inc. Common Stock - USD -Infinity%
Equillium, Inc. 36.08 Million USD 99.64%
Kyverna Therapeutics, Inc. - USD -Infinity%
Coya Therapeutics, Inc. 6 Million USD 97.834%
CNS Pharmaceuticals, Inc. - USD -Infinity%
Galera Therapeutics, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD 79.466%
Dominari Holdings Inc. 2.03 Million USD 93.624%
Edesa Biotech, Inc. - USD -Infinity%
vTv Therapeutics Inc. - USD -Infinity%
Bio-Techne Corporation 1.15 Billion USD 99.989%
Agios Pharmaceuticals, Inc. 26.82 Million USD 99.515%
Harmony Biosciences Holdings, Inc. 582.02 Million USD 99.978%
Prelude Therapeutics Incorporated - USD -Infinity%
Candel Therapeutics, Inc. - USD -Infinity%
iTeos Therapeutics, Inc. 12.59 Million USD 98.968%
Nkarta, Inc. - USD -Infinity%
BioCardia, Inc. 477 Thousand USD 72.746%
Iterum Therapeutics plc - USD -Infinity%